136.0K XNAS Volume
XNAS 18 Mar, 2025 4:01 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Allison Ambrose | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Adam Houghton | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy) | |
| Aaron Deykin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 165,000 | 165,000 | - | - | Stock Option (Right to Buy) | |
| Everett Rand Sutherland | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Michael P. Gray | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Allison Ambrose | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Chimovits Erez | Director, Ten Percent Owner | 15 Oct 2024 | 2,098,000 | 0 | - | - | Series A redeemable convertible preferred stock | ||
| Erez Chimovits | Director, Ten Percent Owner | 15 Oct 2024 | 721,956 | 973,716 | - | - | Common Stock | ||
| Chimovits Erez | Director, Ten Percent Owner | 15 Oct 2024 | 2,887,833 | 3,894,873 | - | - | Common Stock | ||
| Erez Chimovits | Director, Ten Percent Owner | 15 Oct 2024 | 197,456 | 0 | - | - | Series B redeemable convertible preferred stock | ||
| Erez Chimovits | Director, Ten Percent Owner | 15 Oct 2024 | 789,833 | 0 | - | - | Series B redeemable convertible preferred stock | ||
| Chimovits Erez | Director, Ten Percent Owner | 15 Oct 2024 | 524,500 | 0 | - | - | Series A redeemable convertible preferred stock | ||
| Chimovits Erez | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 15 Oct 2024 | 165,000 | 1,138,716 | - | 17 | 2,805,000 | Common Stock |
| Erez Chimovits | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 15 Oct 2024 | 660,000 | 4,554,873 | - | 17 | 11,220,000 | Common Stock |
| Daniella Beckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 34,681 | 34,681 | - | - | Stock Option (Right to Buy) | |
| Erez Chimovits | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 17,096 | 17,096 | - | - | Stock Option (Right to Buy) | |
| Ruddy Marcella Kuhlman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 17,096 | 17,096 | - | - | Stock Option (Right to Buy) | |
| Fleming H. Edward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 17,096 | 17,096 | - | - | Stock Option (Right to Buy) | |
| Ratcliffe Liam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 17,096 | 17,096 | - | - | Stock Option (Right to Buy) | |
| Ronald C. Renaud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 17,096 | 17,096 | - | - | Stock Option (Right to Buy) |